Certara stock.

View the latest Certara Inc. (CERT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Certara, Inc. (CERT) delivered earnings and revenue surprises of 14.29% and 4.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?Latest Software and Certara Inc, Blackbaud Inc Stock News. As of November 22, 2023, Certara Inc had a $2.3 billion market capitalization, compared to the Software median of $426.2 million. Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...

A. The latest price target for Certara ( NASDAQ: CERT) was reported by Stephens & Co. on Wednesday, October 11, 2023. The analyst firm set a price target for 20.00 expecting CERT to rise to within ...Current stock price of Certara, Inc. (CERT) online. Stock quotes and charts for Certara, Inc. (CERT) on the website of Just2Trade broker.

Certara stock ( CERT) appears to check all the boxes. Nominated by one of our lovely subscribers, the New Jerzee-based company serves the drug development industry by offering software and services around its biosimulation platform. It claims to compete indirectly with companies like Schrödinger ( SDGR ), which uses a …Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.

The estimated Net Worth of William F Feehery is at least $68.6 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $35,387,994 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.FDA holds more than 400 Simcyp™ and Phoenix™ software licenses across 12 divisions and officesPRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader ...The high in the last 52 weeks of Certara stock was 24.95. According to the current price, Certara is 58.68% away from the 52-week high. What are analysts …The estimated Net Worth of William F Feehery is at least $59.7 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $26,562,949 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.

11 Des 2020 ... The EQT-backed drug simulation software maker's shares jumped as much as 72% following the company's IPO.

Sifting through countless of stocks in the Software industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Certara Inc because you’re not sure how they measure up, it’s important to compare them ...

Certara Inc. 1699 South Hanley Road. St. Louis, Missouri 63144-2319. Phone 314 647-1099. Industry Software. Sector Technology. Fiscal Year-end N/A. Revenue.Certara, which supplies biosimulation software for customers, undermined investor confidence when it sold 10 million shares for $31. Conversely, Schrödinger made inducement grants of only 7,250 ...The average twelve-month price prediction for Air Products and Chemicals is $320.31 with a high price target of $360.00 and a low price target of $240.00. Learn more on APD's analyst rating history. Do Wall Street analysts like Air Products and Chemicals more than its competitors?Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. Regulatory Adoption. Many global regulatory agencies have adopted use of Certara’s Simcyp PBPK and Phoenix PK/PD platforms. ... Inclusion of Pre-test/Stock Animals in the SEND Dataset.Dec 1, 2023 · Latest Software and Docebo Inc, Certara Inc Stock News. As of December 1, 2023, Docebo Inc had a $1.9 billion market capitalization, compared to the Software median of $398.3 million. Docebo Inc’s stock is NA in 2023, NA in the previous five trading days and up 41.82% in the past year. Currently, Docebo Inc does not have a price-earnings ratio. Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.Find the latest TETRA Technologies, Inc. (TTI) stock quote, history, news and other vital information to help you with your stock trading and investing.

A high-level overview of Twilio Inc. (TWLO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.9 Nov 2023 ... Certara, Inc. (CERT) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate.Nov 23, 2023 · Latest Software and Certara Inc, Blackbaud Inc Stock News. As of November 22, 2023, Certara Inc had a $2.3 billion market capitalization, compared to the Software median of $426.2 million. Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price ... The estimated Net Worth of Leif E Pedersen is at least $6.02 Million dollars as of 31 March 2023. Mr Pedersen owns over 8,646 units of Certara stock worth over $3,161,396 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.John Gallagher CERT stock SEC Form 4 insiders trading. John has made over 9 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently John exercised 5,746 units of CERT stock worth $437,730 on 27 February 2018.. The largest trade John's ever made was exercising 5,746 units of Certara stock …Certara, Inc. Common Stock (CERT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

54.33%. Get the latest Certara Inc (CERT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

Latest Software and Docebo Inc, Certara Inc Stock News. As of December 1, 2023, Docebo Inc had a $1.9 billion market capitalization, compared to the Software median of $398.3 million. Docebo Inc’s stock is NA in 2023, NA in the previous five trading days and up 41.82% in the past year. Currently, Docebo Inc does not have a price-earnings ratio.Find the latest Nerdy, Inc. (NRDY) stock quote, history, news and other vital information to help you with your stock trading and investing.FDA holds more than 400 Simcyp™ and Phoenix™ software licenses across 12 divisions and officesPRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader ...Oct 11, 2023 · PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023. ... stock price by the number of shares outstanding. Certara market cap as of December 01, 2023 is $2.34B. Compare CERT With Other Stocks. Sector, Industry, Market ...Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144: 0001959173-23-003878.pdf ... - Certara - Investor Tools. Print Page. Email Alerts ...Why Certara. Responsibility. Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. Regulatory Adoption. Many global regulatory agencies have adopted use of Certara’s Simcyp PBPK and Phoenix PK/PD platforms. Locations. Discover our global office locations. LeadershipCertara Inc Ordinary Shares 700 Morningstar Rating Unlock Stock XBER Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability …The institutional investor owned 3,910,996 shares of the company's stock after buying an additional 346,460 shares during the quarter. JPMorgan Chase & Co. owned about 2.45% of Certara worth $84,008,000 at the end of the most recent reporting period. A number of other hedge funds have also added to or reduced their stakes in the stock.Or log in with. Google Twitter

Nov 24, 2023 · See the latest Certara Inc Ordinary Shares stock price (700:XBER), related news, valuation, dividends and more to help you make your investing decisions.

Certara Stock Price, News & Analysis (NASDAQ:CERT) $14.64 +0.23 (+1.60%) (As of 12/1/2023 ET) Compare Today's Range $14.12 $14.67 50-Day Range …

Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $57,536 on 31 March 2023.3,990 units of CERT stock worth $57,536 on 31 March 2023.Q3 2023 Certara Inc Earnings Call. Find the latest Certara, Inc. (CERT) stock quote, history, news and other vital information to help you with your stock trading and investing.The high in the last 52 weeks of Certara stock was 24.95. According to the current price, Certara is 58.68% away from the 52-week high. What are analysts …Transaction expected to be accretive to Certara’s revenue, revenue growth and adjusted EBITDA margin. Princeton, N.J., August 5, 2021 – Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has signed a definitive agreement to acquire Pinnacle 21 for $310 million in cash and stock. Pinnacle 21’s …The average twelve-month price prediction for Palantir Technologies is $13.25 with a high price target of $25.00 and a low price target of $5.00. Learn more on PLTR's analyst rating history. Do Wall Street analysts like Palantir Technologies more than its competitors? Analysts like Palantir Technologies less than other Business Services …7 Nov 2022 ... png. Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase. Arsenal will acquire ...The estimated Net Worth of Leif E Pedersen is at least $5.54 Миллион dollars as of 11 September 2023. Mr Pedersen owns over 51,224 units of Certara stock worth over $1,929,379 and over the last 3 years he sold CERT stock worth over $3,311,582. In addition, he makes $295,397 as Pres of Software at Certara.The average twelve-month price prediction for Palantir Technologies is $13.25 with a high price target of $25.00 and a low price target of $5.00. Learn more on PLTR's analyst rating history. Do Wall Street analysts like Palantir Technologies more than its competitors? Analysts like Palantir Technologies less than other Business Services …

Certara is the leading provider of model-informed drug development technology and services, as well as a best-in-class provider of regulatory science, writing, and submission management software and services. Certara’s solutions help inform the drug development and regulatory approval process and address the key efficacy, safety, …Latest Software and Docebo Inc, Certara Inc Stock News. As of December 1, 2023, Docebo Inc had a $1.9 billion market capitalization, compared to the Software median of $398.3 million. Docebo Inc’s stock is NA in 2023, NA in the previous five trading days and up 41.82% in the past year. Currently, Docebo Inc does not have a price-earnings ratio.John Gallagher CERT stock SEC Form 4 insiders trading. John has made over 9 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently John exercised 5,746 units of CERT stock worth $437,730 on 27 February 2018.5,746 units of CERT stock worth $437,730 on 27 February 2018.PRINCETON, N.J.—November 22, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000 shares of its common stock by certain existing stockholders at a public offering price of $31.00 per share.Instagram:https://instagram. worth of 1943 steel pennyiqvia holdingsenergy drink stockscompare futures brokers Certara CERT has an Earnings ESP of +5.41% and sports a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Certara is set to report its first-quarter ...Third Quarter Highlights: Revenue was $85.6 million, PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023. trowe price new horizonsnew edge wealth reviews Mar 10, 2023 · Certara Inc’s (CERT) price is currently up 7.73% so far this month. During the month of March, Certara Inc’s stock price has reached a high of $22.02 and a low of $18.20. Over the last year, Certara Inc has hit prices as high as $24.66 and as low as $10.60. Year to date, Certara Inc’s stock is down 31.32%. forex.com leverage ratio CERT Stock Overview. Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. About the company. CERT fundamental analysis. Snowflake Score. Valuation. 1 /6. Future Growth.Shares of Certara, Inc. (NASDAQ:CERT – Get Free Report) have earned an average recommendation of “Hold” from the eight research firms that are currently covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 …The new Simcyp Discovery Simulator is an intuitive PBPK software that delivers confidence in decision-making during the pre-Investigational New Drug (IND) Application and translational stages. Derived from the gold-standard Simcyp Simulator, Simcyp Discovery advances and accelerates small molecule discovery and development.